Summary:
This UK-based company has developed wearable healthcare technology solutions and integrated healthcare applications, for use by both consumers and professional healthcare providers.
It is looking to develop further the overseas markets for three of its wearable products and services and is interested in both distribution and joint venture agreements with suitable partners. The firm is also open to acting as a subcontractor for other companies in the healthcare technology field.
Description:
This award-winning UK company specialises in the development and marketing of a range of healthcare technology products, with the aim of revolutionising the way health and wellness is measured. Initially, the company focused on the provision of solutions for healthcare professionals, hospitals etc, but more recently it has also developed products targeted at the consumer market.
The wearable devices developed by the company allow for real-time monitoring of a range of clinical physiological data, including the heart rate, respiration, temperature and blood oxygen. These patient vital signs can be measured every second, 24/7, providing clinicians with continuous monitoring and accurate clinical reporting. They are CE marked and FDA approved for medical use.
The product range of the company includes:
• A clinical grade wearable biosensor, comprising a discreet and lightweight patch which sticks to the chest with a skin-friendly hydrocolloid adhesive. The patch measures 8 vital signs in real time including heart and respiration rates, temperature, movement, and ECG (ElectroCardioGram), allowing monitoring of the wearer in real-time, continuously around the clock and in various care settings including the home. It is both durable (up to 7 days’ battery life) and fully disposable.
• A wearable health monitor, suitable for clinical settings, where it can be used by healthcare providers to monitor the patient continuously, both inside and out of hospital. This solution combines the company’s fully-disposable, single-use vital signs biosensor with powerful analytics and learning. Data is sent in real-time via Bluetooth to mobiles and the cloud for monitoring and analysis by clinicians, who are able to see individual patients’ vital signs data, as well as patient histories, raw data and reports. Alert / alarm notifications are also included.
The company also offers a mobile cardiac monitoring service, where its wearable biosensor patch is used to provide a near flawless and wireless ECG signal continuously for 7 days. This signal is delivered in real-time to the company’s servers, where its CE marked AI-based ECG analysis solution enables physicians to view the patient’s status at any time. The patch replaces the cumbersome equipment which patients have traditionally been required to wear in order to monitor the heart’s performance and provides their doctors with instant results and analysis.
The company’s products were initially launched in the UK, but are now being marketed globally. Demand is strong, particularly in the light of the current Covid-19 pandemic, with clients in Europe, the USA, South Africa and South East Asia. As part of its on-going international growth strategy, the company wishes to find new partners overseas and is open to potential collaboration in three ways:
• The appointment of distributors, ideally with experience of selling complementary products in the healthcare technology market;
• The creation of a joint venture with a partner willing to collaborate in the development of the market for wearable healthcare technologies and interested to add to the UK firm’s current offer;
• Through offering hardware and software services, on the basis of a subcontracting agreement.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
Partners should be experienced in the healthcare field and will probably be offering products / services which complement the UK company's offer or be working in complementary health technology sectors.
Appointed distributors should have excellent links into the healthcare market and ideally would be able to provide technical support if required. They would be required to promote and sell the UK company’s product offer.
Joint venture partners would probably be offering complementary healthcare technologies or services but must be willing to set up a joint operation, as a way of adding value to their current offer.
Other potential partners will be wearable healthcare device manufacturers seeking to partner with the UK firm for development / production of their healthcare technology solutions (hardware and / or software) on a subcontract basis.
Stage of Development:
Already on the market
External code:
BOUK20210120004
